Logo image
Extracorporeal corporeal membrane oxygenation: indications, technical considerations, and future trends
Journal article   Open access

Extracorporeal corporeal membrane oxygenation: indications, technical considerations, and future trends

Elizabeth M. Staley, Geoffrey D. Wool, Huy P. Pham, Heidi J. Dalton and Edward C.C. Wong
Annals of Blood, Vol.7
2022

Abstract

antifibrinolytic agent antithrombin fibrinogen concentrate hemostatic agent heparin prothrombin complex thrombin inhibitor anticoagulation bleeding blood component blood component therapy blood transfusion clinical assessment clinical feature clinical practice clinical protocol congenital diaphragm hernia congenital heart malformation coronavirus disease 2019 critically ill patient cryoprecipitate erythrocyte erythrocyte transfusion evidence based practice extracorporeal oxygenation fluid therapy health service heart arrest hematologic disease human meconium aspiration meta analysis (topic) multicenter study (topic) patient monitoring persistent pulmonary hypertension plasma exchange plasma transfusion priority journal randomized controlled trial (topic) rapid deployment ecmo Review risk assessment risk factor thrombocyte thrombocyte transfusion thrombosis tissue oxygenation treatment indication treatment outcome veno-arterial ECMO veno-venous ECMO viscoelasticity
The extracorporeal membrane oxygenation (ECMO) device was initially developed with the goal of providing extended support in patients experiencing cardiac failure. However, ECMO technology has evolved, and now provides a means to successfully manage patients experiencing cardiac and/or pulmonary failure until such time as the patient's body is able to either heal, or undergo transplantation. In addition, it has been used in the management of multisystem organ dysfunction. The life-saving utility of this therapy for critically ill patients has prompted world-wide implementation particularly in resource-rich settings. Innovations in instrumentation, broad clinical implementation, extensive utilization of blood and blood components, and the catastrophic nature of potential complications, have collectively prompted the evolution of a tremendous body of research. In this comprehensive review we briefly describe the early development of the ECMO device and technology, in addition to outlining the function of the device as it now commonly utilized including veno-arterial (VA) vs. veno-venous (VV) and rapid deployment ECMO. This review will also delineate the rationale for ECMO use, common clinical indications, and specialized techniques, in addition to the approaches necessary for their successful implementation. As systemic anticoagulation is frequently utilized to support patients on ECMO, the review also contains an extensive review of anticoagulation management, blood component utilization, and potential hematologic complications of ECMO. The review includes a discussion of more recent trends including the use of ECMO in COVID-19 patients, and the performance of tandem plasma exchange. Finally, areas of current controversy and needed research will be highlighted. © 2022 The authors.
url
https://doi.org/10.21037/aob-21-85View
Published (Version of record) Open

Metrics

17 Record Views

Details

Logo image